Vertiflex to use $40M financing round funds for device market expansion: 5 points Featured

Written by  Megan Wood | Wednesday, 08 March 2017 18:08
Social sharing

Carlsbad, Calif.-based Vertiflex completed a $40 million financing round.

Here are five points:


1. Vertiflex develops minimally invasive interventions for spinal stenosis.


2. Endeavour Vision and H.I.G. BioHealth Partners, both new investors, led the financing round.


3. Existing investors, New Enterprise Associates, Thomas, McNerney & Partners and Alta Partners also led the round.


4. Vertiflex will use most of the funds for the U.S. commercial expansion of the Superion Indirect Decompression System, which is a MIS implant for treating lumbar spinal stenosis.


5. The Superion device, labeled an American Medical Association Current Procedural Terminology Category I code, is designed to decrease pressure on impacted nerves.


More articles on MIS:
Inspired Spine hosts surgeon training for MIS procedures in cadaver lab: 5 highlights
Vertos Medical receives CMS broad coverage approval for mild procedure: 5 key notes
5 notes on bilateral percutaneous fixation in MIS spine surgery


Last modified on Thursday, 09 March 2017 20:20
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.